Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-000899-40Phase 3Completed
Phase 3, single-arm trial of metformin in impaired fasting glucose (IFG) and prediabetes, sponsored by Laboratori Guidotti. Primary endpoint: Whole body insulin sensitivity index (ISI-Matsuda). Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-000899-40.